148 related articles for article (PubMed ID: 33468858)
1. [Nodular Lymphocyte-Predominant Hodgkin Lymphoma(NLPHL)Which Originate from the Mesentery-A Series of Two Cases].
Zenitani S; Imasato M; Iwamoto K; Nakahara Y; Mikamori M; Naito A; Ohtsuka M; Furukawa K; Moon J; Asaoka T; Kishi K; Akamatsu H
Gan To Kagaku Ryoho; 2020 Dec; 47(13):1875-1877. PubMed ID: 33468858
[TBL] [Abstract][Full Text] [Related]
2. [Differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma].
Liu YH; Zhuang HG; Lin HL; Wu QL; Luo DL; Li L; Luo XL
Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):594-8. PubMed ID: 17243292
[TBL] [Abstract][Full Text] [Related]
3. A high number of IgG4-positive plasma cells rules out nodular lymphocyte predominant Hodgkin lymphoma.
Kiil K; Bein J; Schuhmacher B; Thurner L; Schneider M; Hansmann ML; Hartmann S
Virchows Arch; 2018 Dec; 473(6):759-764. PubMed ID: 30259184
[TBL] [Abstract][Full Text] [Related]
4. Role of FNA with core biopsy or cell block in patients with nodular lymphocyte-predominant Hodgkin lymphoma.
Gupta S; Long SR; Natkunam Y; Kong CS; Gupta NK; Gratzinger D
Cancer Cytopathol; 2020 Aug; 128(8):570-579. PubMed ID: 32343479
[TBL] [Abstract][Full Text] [Related]
5. Bone Marrow Involvement in Patients With Nodular Lymphocyte Predominant Hodgkin Lymphoma.
Agbay RLMC; Loghavi S; Zuo Z; Fayad L; Dabaja B; Medeiros LJ; Khoury JD
Am J Surg Pathol; 2018 Apr; 42(4):492-499. PubMed ID: 29309302
[TBL] [Abstract][Full Text] [Related]
6. Does functional imaging distinguish nodular lymphocyte-predominant hodgkin lymphoma from T-cell/histiocyte-rich large B-cell lymphoma?
Barber NA; Loberiza FR; Perry AM; Bast M; Holdeman KP; Esfahane AB; Weisenburger DD; Vose J; Bierman P; Armitage JO; Bociek RG
Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):392-7. PubMed ID: 23773450
[TBL] [Abstract][Full Text] [Related]
7. [Nodular lymphocyte-predominant Hodgkin lymphoma in children: clinical course, biology, and management].
Gorde-Grosjean S; Guimard G; Lambilliotte A; Coulomb-Lhermine A; Montravers F; Landman-Parker J
Bull Cancer; 2014 Sep; 101(9):881-90. PubMed ID: 25296072
[TBL] [Abstract][Full Text] [Related]
8. PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma.
Nam-Cha SH; Roncador G; Sanchez-Verde L; Montes-Moreno S; Acevedo A; Domínguez-Franjo P; Piris MA
Am J Surg Pathol; 2008 Aug; 32(8):1252-7. PubMed ID: 18594468
[TBL] [Abstract][Full Text] [Related]
9. Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Review of Current Literature and Case Discussion.
Sidda A; Naleid NK; Manu G; Graffeo V; Jamil MO
J Investig Med High Impact Case Rep; 2022; 10():23247096221111767. PubMed ID: 35861500
[TBL] [Abstract][Full Text] [Related]
10. Immunoarchitectural patterns in nodular lymphocyte predominant Hodgkin lymphoma: pathologic and clinical implications.
Gloghini A; Bosco A; Ponzoni M; Spina M; Carbone A
Expert Rev Hematol; 2015 Apr; 8(2):217-23. PubMed ID: 25487651
[TBL] [Abstract][Full Text] [Related]
11. Nodular lymphocyte predominant Hodgkin lymphoma: Clincopathological study of 25 cases from Japan with a reappraisal of tissue associated macrophages.
Eladl AE; Satou A; Elsayed AA; Suzuki Y; Shimizu-Kohno K; Kato S; Tomita A; Kinoshita T; Nakamura S; Asano N
Pathol Int; 2015 Dec; 65(12):652-60. PubMed ID: 26538151
[TBL] [Abstract][Full Text] [Related]
12. Atypical variants of nodular lymphocyte-predominant Hodgkin lymphoma show low microvessel density and vessels of distention type.
Scheidt V; Hansmann ML; Schuhmacher B; Döring C; Hartmann S
Hum Pathol; 2017 Feb; 60():129-136. PubMed ID: 27816718
[TBL] [Abstract][Full Text] [Related]
13. Intraparotid classical and nodular lymphocyte-predominant Hodgkin lymphoma: pattern analysis with emphasis on associated lymphadenoma-like proliferations.
Agaimy A; Wild V; Märkl B; Wachter DL; Hartmann A; Rosenwald A; Ihrler S
Am J Surg Pathol; 2015 Sep; 39(9):1206-12. PubMed ID: 25929348
[TBL] [Abstract][Full Text] [Related]
14. Nodular Lymphocyte Predominant Hodgkin Lymphoma With Aberrant Immunophenotype or Variant Histopathology: Insights From Case Series of Three Patients.
Chander G; Dassanayake H; Kaparou M; Ahmed M; Kishore B; Nikolousis E; Kanellopoulos A
Anticancer Res; 2021 Aug; 41(8):4017-4020. PubMed ID: 34281867
[TBL] [Abstract][Full Text] [Related]
15. Unfavorable presentation but comparable outcome: Presentation and outcome of children with nodular lymphocyte predominant Hodgkin lymphoma from India.
Prasad M; Narula G; Chinnaswamy G; Arora B; Shet T; Panjwani P; Sengar M; Laskar S; Khanna N; Banavali S
Pediatr Blood Cancer; 2018 Oct; 65(10):e27288. PubMed ID: 29893471
[TBL] [Abstract][Full Text] [Related]
16. Primary Extranodal Nodular Lymphocyte Predominant Hodgkin Lymphoma Involving the Thyroid.
Williams TP; Raess PW; Braziel R; Cascio MJ
Head Neck Pathol; 2020 Jun; 14(2):550-553. PubMed ID: 31292857
[TBL] [Abstract][Full Text] [Related]
17. Highly recurrent mutations of SGK1, DUSP2 and JUNB in nodular lymphocyte predominant Hodgkin lymphoma.
Hartmann S; Schuhmacher B; Rausch T; Fuller L; Döring C; Weniger M; Lollies A; Weiser C; Thurner L; Rengstl B; Brunnberg U; Vornanen M; Pfreundschuh M; Benes V; Küppers R; Newrzela S; Hansmann ML
Leukemia; 2016 Apr; 30(4):844-53. PubMed ID: 26658840
[TBL] [Abstract][Full Text] [Related]
18. How I treat nodular lymphocyte-predominant Hodgkin lymphoma.
Eichenauer DA; Engert A
Blood; 2020 Dec; 136(26):2987-2993. PubMed ID: 32877522
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and outcomes of patients with nodular lymphocyte-predominant Hodgkin lymphoma versus those with classical Hodgkin lymphoma: a population-based analysis.
Gerber NK; Atoria CL; Elkin EB; Yahalom J
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):76-83. PubMed ID: 25863756
[TBL] [Abstract][Full Text] [Related]
20. [Diagnosis and staging of Hodgkin lymphoma].
Ghesquières H
Rev Prat; 2023 Jun; 73(6):617-620. PubMed ID: 37458549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
